logo
Book a meeting
Pascal Biosciences

Pascal Biosciences

Biotechnology, 4000 Mason Rd, Seattle, Washington, 98195, United States, 1-10 Employees

pascalbiosciences.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: +12*********

Who is PASCAL BIOSCIENCES

Pascal Biosciences is a biotechnology company focused on advancing innovative approaches for the treatment of cancer including cannabinoid-based therapeutics and targeted therapies. The c...

Read More

lock icon Get Full Access
map
  • 4000 Mason Rd, Seattle, Washington, 98195, United States Headquarters: 4000 Mason Rd, Seattle, Washington, 98195, United States
  • 2013 Date Founded: 2013
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8731

checked-icon Does something look wrong? Fix it. | View contact records from PASCAL BIOSCIENCES

Pascal Biosciences Org Chart and Mapping

Employees
Christi Wood

Christi Wood

Staff Scientist

See Full Org Chart arrow
email-formate-icon
View Email Formats for Pascal Biosciences
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding Pascal Biosciences

Answer: Pascal Biosciences's headquarters are located at 4000 Mason Rd, Seattle, Washington, 98195, United States

Answer: Pascal Biosciences's phone number is +12*********

Answer: Pascal Biosciences's official website is https://pascalbiosciences.com

Answer: Pascal Biosciences's revenue is $1 Million to $5 Million

Answer: Pascal Biosciences's SIC: 8731

Answer: Pascal Biosciences has 1-10 employees

Answer: Pascal Biosciences is in Biotechnology

Answer: Pascal Biosciences contact info: Phone number: +12********* Website: https://pascalbiosciences.com

Answer: Pascal Biosciences is a biotechnology company focused on advancing innovative approaches for the treatment of cancer including cannabinoid-based therapeutics and targeted therapies. The companys leading cannabinoid portfolio comprises a small molecule therapeutic, ST-403, that is advancing into clinical trials for the treatment of glioblastoma, and an immuno-stimulatory molecule. In addition, Pascal Biosciences is developing a B-cell targeted antibody for acute lymphoblastic leukemia and an antibody for calcium channels expressed by the immune system. Pascal is headquartered in Vancouver, Canada. The company trades on the TSX Venture Exchange under the symbol PAS.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access